NewSenior Biostatistician (Translational and Exploratory Biostatistics) Genentech IncSenior Biostatistician (Translational and Exploratory Biostatistics)South San Francisco, CA$136,900–$254,200 / yearAs trusted analytical partners in end-to-end drug development, Biostatistics leverages data to drive scientifically rigorous programmatic decisions across Roche's Development portfolio; Biostatistics designs robust trials and analysis plans that increase the probability of technical success, accelerating timelines to advance Roche's clinical pipeline and promote regulatory success - ultimately bringing medicines to our patients faster. You will be responsible for providing strategic statistical input and hands-on execution for both traditional late-phase studies and complex exploratory initiatives, utilizing multimodal data - including biomarkers, imaging, and digital health measurements - to advance high-value work and inform molecule-level development decisions.
Director, Biostatistics Summit Therapeutics plcDirector, BiostatisticsPalo Alto, CAOverview of Role: Serves as the project level biostatistician and provides leadership within biostatistics function to develop and execute statistical strategy, study design, statistical analyses, and regulatory submissions for clinical trials in oncology. Experience, Education and Specialized Knowledge and Skills: PhD and a minimum of 8+ years of experience or Masters (MS) and a minimum of 11+ years of experience in statistics or biostatistics or related disciplines with clinical trials, pharmaceutical/biotech industry, or healthcare experience.
Director, Biostatistics Summit TherapeuticsDirector, BiostatisticsPalo Alto, CaliforniaHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Serves as the project level biostatistician and provides leadership within biostatistics function to develop and execute statistical strategy, study design, statistical analyses, and regulatory submissions for clinical trials in oncology.
Executive Director, Biostatistics Exelixis Inc.Executive Director, BiostatisticsAlameda, CA$271,000–$385,000 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of 16 years of related experience; or, PhD in Statistics/Biostatistics or related discipline and a minimum of 15 years of related experience; or, Equivalent combination of education and relevant experience in oncology. SUMMARY/JOB PURPOSE: Leads the biostatistics function in developing statistical strategy, design, and analyses for conducting clinical trials in all phases for multiple compounds.
Sr Director, Biostatistics Exelixis Inc.Sr Director, BiostatisticsAlameda, CA$248,000–$352,500 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of 13 years of related experience; or, PhD in Statistics/Biostatistics or related discipline and a minimum of 12 years of related experience; or, Equivalent combination of education and relevant experience in oncology. SUMMARY/JOB PURPOSE: Provides leadership to the biostatistics function and direct management of biostatistics staff in developing statistical strategy, design, and analyses for clinical trials for multiple compounds with a focus on early phase (1/2) trials.
Senior Director, Safety Biostatistics Ideaya Biosciences IncSenior Director, Safety BiostatisticsSouth San Francisco, CA$270,000–$334,000 / yearThe Senior Director of Safety Biostatistics will be a leader of Biostatistics and Biometrics at IDEAYA and will oversee and provide strong statistical support to the development of IDEAYA therapeutics in close collaboration with Clinical Development, Regulatory Affairs, Data Management, Program Management, and especially with focus with Drug Safety and Pharmacovigilance. Non-Solicitation Policy and Notice to Agencies and Recruiters: IDEAYA's Non-Solicitation Policy strictly prohibits agencies and recruiters from any contact and communication with IDEAYA employees, managers, and leaders to submit unsolicited candidate resumes and/or to solicit business partnerships.
Associate Director, Biostatistics Summit Therapeutics plcAssociate Director, BiostatisticsPalo Alto, CAReview the accuracy of clinical data, perform statistical analysis, ensure the application of appropriate statistical methods, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final clinical study reports. Partners with cross-functional team members in ensuring accuracy/consistency of clinical data and exceptional delivery, interpretation of clinical results, and assists in the development and review of regulatory submission documents.
Associate Director, Biostatistics Summit TherapeuticsAssociate Director, BiostatisticsPalo Alto, CaliforniaHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Review the accuracy of clinical data, perform statistical analysis, ensure the application of appropriate statistical methods, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final clinical study reports.
Associate Biostatistics Director Exelixis Inc.Associate Biostatistics DirectorAlameda, CA$166,500–$236,500 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in related discipline and a minimum of 9 years of related experience; or, PhD in related discipline and a minimum of 5 years of related experience; or, Equivalent combination of education and experience. Works collaboratively with clinicians, data managers, biostatisticians, statistical programmers, and medical writers in the planning, conduct and analysis of clinical trials.
Assoc Biostatistics Director Exelixis IncAssoc Biostatistics DirectorAlameda, CA$166,500–$236,500 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in related discipline and a minimum of 9 years of related experience; or, PhD in related discipline and a minimum of 5 years of related experience; or, Equivalent combination of education and experience. Works collaboratively with clinicians, data managers, biostatisticians, statistical programmers, and medical writers in the planning, conduct and analysis of clinical trials.
Vice President, Biostatistics Exelixis Inc.Vice President, BiostatisticsAlameda, CA$360,000–$418,000 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: BA/BS in related discipline and a minimum of twenty-one years of relevant experience in the pharmaceutical industry; or, MA/MS in related discipline and a minimum of nineteen years of relevant experience in the pharmaceutical industry; or, PhD in related discipline and a minimum of seventeen years of relevant experience in the pharmaceutical industry; or, Equivalent combination of education and experience. ESSENTIAL DUTIES AND RESPONSIBILITIES: In collaboration with the product development teams and through subordinate management, leads the effective development and implementation of strategies consistent with the company's strategic objectives, and ensures the overall effective operations of the biostatistics, and Biostatistics associated tools and processes.
Director, Biostatistics TempusDirector, BiostatisticsRedwood City, CA$180,000–$240,000 / yearWe are seeking a highly motivated and capable Director of Biostatistics to lead a team of biostatisticians involved in multiple aspects of clinical research at Tempus. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Senior Manager, Biostatistics Corcept TherapeuticsSenior Manager, BiostatisticsRedwood City, CA$165,150–$242,820 / yearWith advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. The pay range that the Company reasonably expects to pay for this headquarters-based position is $165,150 - $242,820; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Associate Director, Biostatistics Corcept TherapeuticsAssociate Director, BiostatisticsRedwood City, CA$183,500–$269,800 / yearWith advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. The pay range that the Company reasonably expects to pay for this headquarters-based position is $183,500 - $269,800; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Director, Biostatistics, Late Clinical Stage Revolution Medicines, Inc.Director, Biostatistics, Late Clinical StageRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and studies in clinical late-stage development and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Director, Biostatistics, Early Phase Revolution Medicines, Inc.Director, Biostatistics, Early PhaseRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Biostatistics Clinical Late Stage Revolution Medicines, Inc.Associate Director, Biostatistics Clinical Late StageRedwood City, CA$186,000–$233,000 / yearLeveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Sr. Director, Biostatistics ALX Oncology Inc.Sr. Director, BiostatisticsSouth San Francisco, CA$240,000Approximately 12+ years of progressive Biostatistics experience within biotechnology, pharmaceutical, or CRO environments, including Phase I-III oncology clinical studies, with demonstrated success leading statistical strategy for registrational clinical trials, partnering across cross-functional teams, and supporting global regulatory submissions. The Senior Director, Biostatistics provides strategic statistical leadership across ALX Oncology's clinical development portfolio, partnering cross-functionally to design, execute, analyze, and interpret clinical studies that support regulatory submissions and advance innovative oncology therapies.
Sr. Director, Biostatistics ALX Oncology Holdings IncSr. Director, BiostatisticsSouth San Francisco, CA$240,000–$280,000 / yearApproximately 12+ years of progressive Biostatistics experience within biotechnology, pharmaceutical, or CRO environments, including Phase I-III oncology clinical studies, with demonstrated success leading statistical strategy for registrational clinical trials, partnering across cross-functional teams, and supporting global regulatory submissions. The Senior Director, Biostatistics provides strategic statistical leadership across ALX Oncology's clinical development portfolio, partnering cross-functionally to design, execute, analyze, and interpret clinical studies that support regulatory submissions and advance innovative oncology therapies.
Senior Manager, Biostatistics Bristol Myers SquibbSenior Manager, BiostatisticsBrisbane, CA$188,730–$228,701 / yearBased on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day. Each of us is empowered to apply our individual talents and unique perspectives in a supportive culture, promoting global participation in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.